SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C4 - Multiple Sclerosis Essentials

Event Time: Saturday April 22, 2017 8:00 am to 10:00 am
Topic(s): MS and CNS Inflammatory Disease
Director(s): Stephen Krieger MD, FAAN
Description: Faculty will use a series of illustrative cases to bring participants up-to-date on current diagnosis and management of multiple sclerosis and other demyelinating disorders. Participants will be able to exercise their own judgment at multiple decision nodes as each case unfolds, and compare their choices with those of their peers and faculty. Cases have been carefully selected to represent real situations regularly encountered in the practice of two expert MS clinicians.
Completion Message: Participants should be familiar with current issues related to the diagnosis and treatment of patients with multiple sclerosis and related demyelinating disorders, and should recognize areas of both consensus and controversy in the field.
CME Credits: 2
Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement

Program Speakers - Tentative

Start/End Time Title Faculty
8:00 AM - 10:00 AM Challenging Demyelinating Disease Cases Stephen Krieger MD, FAAN, Aaron Miller MD, FAAN 

Disclosures

Speaker Disclosure
Stephen Krieger, MD, FAAN Dr. Krieger has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with acorda, bayer, biogen, emd serono, genentech, genzyme, mallinckrodt, medday, novartis, teva, and tg therapeutics .

Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Accordant Health Services (Caremark), Adama, BiogenIdec, Celgene, Genzyme/Sanofi, Mallinckrodt, Mapi-Pharma, Novartis, Roche/Genentech. Dr. Miller has received personal compensation in an editorial capacity for Continuum Audio. Dr. Miller has received research support from BiogenIdec,Genzyme/sanofi, Mallickrodt, Novartis, Roche/Genentech, MedDay.

Register Now

Related Courses

Saturday April 21, 2018

9:30 AM-11:30 AM
C11 Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C33 Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
3:30 PM-5:30 PM
C57 Spanish: Update on MS Therapy Lilyana Amezcua MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C97 Multiple Sclerosis Overview I: Clinical Pearls John Corboy MD, FAAN
1:00 PM-3:00 PM
C107 Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
3:30 PM-5:30 PM
C121 Multiple Sclerosis Overview III: Basic and Translational Science Michael Racke MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C135 Multiple Sclerosis Therapy: Disease-modifying Treatment I David Jones MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C146 Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
3:30 PM-5:30 PM
C161 Multiple Sclerosis Therapy: Symptom Management Jonathan Carter MD

Thursday April 26, 2018

7:00 AM-9:00 AM
C174 Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
1:00 PM-3:00 PM
N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis Eric Klawiter MD,
Ellen Mowry MD, FAAN

Friday April 27, 2018

1:00 PM-3:00 PM
C223 Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN

MEMBER LOG IN

Forgot Password?